Skip to main content

and
  1. Article

    Open Access

    Pyruvate dehydrogenase operates as an intramolecular nitroxyl generator during macrophage metabolic reprogramming

    M1 macrophages enter a glycolytic state when endogenous nitric oxide (NO) reprograms mitochondrial metabolism by limiting aconitase 2 and pyruvate dehydrogenase (PDH) activity. Here, we provide evidence that N...

    Erika M. Palmieri, Ronald Holewinski, Christopher L. McGinity in Nature Communications (2023)

  2. Article

    Open Access

    Itaconic acid underpins hepatocyte lipid metabolism in non-alcoholic fatty liver disease in male mice

    Itaconate, the product of the decarboxylation of cis-aconitate, regulates numerous biological processes. We and others have revealed itaconate as a regulator of fatty acid β-oxidation, generation of mitochondrial...

    Jonathan M. Weiss, Erika M. Palmieri, Marieli Gonzalez-Cotto in Nature Metabolism (2023)

  3. No Access

    Article

    The promise and peril of targeting cell metabolism for cancer therapy

    A major challenge of cancer immunotherapy is the potential for undesirable effects on bystander cells and tumor-associated immune cells. Fundamentally, we need to understand what effect targeting tumor metabol...

    Jonathan M. Weiss in Cancer Immunology, Immunotherapy (2020)

  4. Article

    Open Access

    Tumour-elicited neutrophils engage mitochondrial metabolism to circumvent nutrient limitations and maintain immune suppression

    Neutrophils are a vital component of immune protection, yet in cancer they may promote tumour progression, partly by generating reactive oxygen species (ROS) that disrupts lymphocyte functions. Metabolically, ...

    Christopher M. Rice, Luke C. Davies, Jeff J. Subleski in Nature Communications (2018)

  5. Article

    Open Access

    ROCK2, but not ROCK1 interacts with phosphorylated STAT3 and co-occupies TH17/TFH gene promoters in TH17-activated human T cells

    Rho-associated coiled-coil kinase (ROCK)2 targeting down-regulates autoimmune responses in animal models and patients, however the underlying molecular mechanism is still an enigma. We report that ROCK2 binds ...

    Wei Chen, Melanie S. Nyuydzefe, Jonathan M. Weiss, **gya Zhang in Scientific Reports (2018)

  6. No Access

    Article

    Killer immunoglobulin-like receptor (KIR) and KIR–ligand genotype do not correlate with clinical outcome of renal cell carcinoma patients receiving high-dose IL2

    NK cells play a role in many cancer immunotherapies. NK cell activity is tightly regulated by killer immunoglobulin-like receptor (KIR) and KIR–ligand interactions. Inhibitory KIR–ligands have been identified ...

    Wei Wang, Amy K. Erbe, Mikayla Gallenberger in Cancer Immunology, Immunotherapy (2016)

  7. Article

    Open Access

    CD40 expression in renal cell carcinoma correlates with tumor apoptosis, CD8 T cell frequency and patient survival

    Jonathan M Weiss, Gregory Alvord, Octavio A Quinones in Journal for ImmunoTherapy of Cancer (2013)

  8. Article

    Open Access

    Hepatic myeloid-derived suppressor cells in tumor bearing mice exacerbate hepatitis and transform into pro-inflammatory myeloid cells

    Jose Medina-Echeverz, Tamar Kapanadze, Chi Ma in Journal for ImmunoTherapy of Cancer (2013)

  9. No Access

    Chapter

    The Role of Myeloid Derived Suppressor Cells in Cancer

    Inflammation is established as one of the central hallmarks of cancer. Although the immune system plays an indispensable role in immunosurveillance against cellular transformation, ample evidence demonstrates ...

    Jonathan M. Weiss in The Tumor Immunoenvironment (2013)

  10. No Access

    Article

    IFN-γ mediates CD4+ T-cell loss and impairs secondary antitumor responses after successful initial immunotherapy

    Protective cell-mediated immune responses in cancer are critically dependent on T-helper type 1 (TH1) cytokines such as interferon-γ (IFN-γ). We have previously shown that the combination of CD40 stimulation and ...

    Vanessa Berner, Haiyan Liu, Qing Zhou, Kory L Alderson, Kai Sun in Nature Medicine (2007)

  11. No Access

    Article

    Rapid, in vivo, evaluation of antiangiogenic and antineoplastic gene products by nonviral transfection of tumor cells

    Using a nonviral, electroporation-based gene transfection approach, we demonstrate the efficient and consistent transfection of two poorly immunogenic tumor cell lines: B16F10 melanoma and renal carcinoma (REN...

    Jonathan M Weiss, Rama Shivakumar, Stephanie Feller, Lin-Hong Li in Cancer Gene Therapy (2004)